Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Lodde

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Nutrients|March 29, 2023
Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA)Hanane Moussa, Karine Robitaille, Jean-François Pelletier, et al.
Future Oncology (London, England)|March 12, 2015
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patientsOrazio Caffo, Giovanni Lo Re, Teodoro Sava, et al.
BJU International|January 25, 2025
Comparing open and video endoscopic lymphadenectomy for penile cancer: a systematic review and meta-analysis of prospective studiesCaio Vinícius Suartz, Richard Dobrucki de Lima, Luiza Rafih Abud, et al.
The Journal of Urology|October 17, 2022
Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index ThresholdLouise Catherine McLoughlin, Wassim Kassouf, Rodney H Breau, et al.
BMJ Open|May 28, 2026
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer riskHanane Moussa, Roxane Tourigny, Karine Robitaille, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 17, 2026
Trajectory timelines and treatment efficacy of <sup>177</sup>Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian centerFrédéric Pouliot, Michele Lodde, Marjorie Besançon, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 8, 2025
Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database: The Canadian CBCIS experienceHanaa Fekak, Wassim Kassouf, Rodney H Breau, et al.
Communications Medicine|March 23, 2024
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferationKarine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2020
A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicineBruno Turcotte, Sophie Paquet, Anne-Sophie Blais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort StudyFrédéric Pouliot, Fred Saad, Etienne Rousseau, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Nutrients|March 29, 2023
Effects of Concentrated Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplementation on Quality of Life after Radical Prostatectomy: A Phase II Randomized Placebo-Controlled Trial (RCT-EPA)Hanane Moussa, Karine Robitaille, Jean-François Pelletier, et al.
Future Oncology (London, England)|March 12, 2015
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patientsOrazio Caffo, Giovanni Lo Re, Teodoro Sava, et al.
BJU International|January 25, 2025
Comparing open and video endoscopic lymphadenectomy for penile cancer: a systematic review and meta-analysis of prospective studiesCaio Vinícius Suartz, Richard Dobrucki de Lima, Luiza Rafih Abud, et al.
The Journal of Urology|October 17, 2022
Obesity and Complication Risk From Radical Cystectomy: Identifying a Body Mass Index ThresholdLouise Catherine McLoughlin, Wassim Kassouf, Rodney H Breau, et al.
BMJ Open|May 28, 2026
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer riskHanane Moussa, Roxane Tourigny, Karine Robitaille, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 17, 2026
Trajectory timelines and treatment efficacy of <sup>177</sup>Lu-PSMA-617 radioligand therapy for metastatic castration-resistant prostate cancer: Real-world data from 50 consecutive cases treated in a single Canadian centerFrédéric Pouliot, Michele Lodde, Marjorie Besançon, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 8, 2025
Comparison of 90-day morbidity and mortality between ileal conduit and orthotopic neobladder following radical cystectomy in a large multi-institutional database: The Canadian CBCIS experienceHanaa Fekak, Wassim Kassouf, Rodney H Breau, et al.
Communications Medicine|March 23, 2024
A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferationKarine Robitaille, Marie-Hélène Guertin, Afshin Jamshidi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2020
A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicineBruno Turcotte, Sophie Paquet, Anne-Sophie Blais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort StudyFrédéric Pouliot, Fred Saad, Etienne Rousseau, et al.
Pageof 7